# An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/an-index-of-the-three-core-data-set-patient-questionnaire-measures-distinguishes/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Theodore Pincus,Vibeke Strand,Gary G. Koch,Ingrid A. Amara,Bruce Crawford,Frederick Wolfe,Stanley Cohen,David T. Felson |
| Citations | 146 |
| DOI | 10.1002/art.10824 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1973562603 |
| PMID | 12632413 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Bruce Crawford](https://scholariq.org/researchers/bruce-crawford/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Musculoskeletal Disorders and Rehabilitation](https://scholariq.org/topics/musculoskeletal-disorders-and-rehabilitation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.